Managing Editor – Europe
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Tom Gallen
GSK has launched Flunase in Japan following the switch of fluticasone propionate. JSMI’s Toshi Tominaga gives his assessment of the product’s prospects as an OTC drug.
A six-month suspension from sale has been handed to 23 ranitidine drugs sold in Australia. The country's regulator has suggested all 23 are facing a permanent ban over patient safety fears.
Africa represents a new frontier for health and beauty firms. With significant economic growth and a population explosion forecast for the continent, now is the perfect time to start thinking about the Africa opportunity, market expert Ben Longman told the recent Ceuta International Conference.